AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
THE 20210A ALLELE OF THE PROTHROMBIN GENE - A RISK FACTOR FOR JUVENILE STROKE - RESULT OF A PILOT-STUDY
Authors: HALBMAYER WM HAUSHOFER A HERMANN KM FISCHER M
Citation: Wm. Halbmayer et al., THE 20210A ALLELE OF THE PROTHROMBIN GENE - A RISK FACTOR FOR JUVENILE STROKE - RESULT OF A PILOT-STUDY, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 209-210
APC RESISTANCE AND FACTOR-V-LEIDEN (FV-Q(506)) MUTATION IN PATIENTS WITH ISCHEMIC CEREBRAL EVENTS
Authors: HALBMAYER WM HAUSHOFER A ANGERER V FINSTERER J FISCHER M
Citation: Wm. Halbmayer et al., APC RESISTANCE AND FACTOR-V-LEIDEN (FV-Q(506)) MUTATION IN PATIENTS WITH ISCHEMIC CEREBRAL EVENTS, Blood coagulation & fibrinolysis, 8(6), 1997, pp. 361-364
FIRST EXPERIENCE WITH A NEW FUNCTIONAL SCREENING ASSAY FOR THE PROTEIN-C PATHWAY - PROC(R) GLOBAL
Authors: HALBMAYER WM ANGERER V FISCHER M WAGNER C
Citation: Wm. Halbmayer et al., FIRST EXPERIENCE WITH A NEW FUNCTIONAL SCREENING ASSAY FOR THE PROTEIN-C PATHWAY - PROC(R) GLOBAL, Thrombosis and haemostasis, 1997, pp. 118-118
FACTOR-XII DEFICIENCY AND CORONARY HEART-SURGERY - RESULTS OF A PROSPECTIVE 3 YEARS FOLLOW-UP-STUDY
Authors: HALBMAYER WM HAUSHOFER A ANGERER V RADEK J DEUTSCH M FISCHER M
Citation: Wm. Halbmayer et al., FACTOR-XII DEFICIENCY AND CORONARY HEART-SURGERY - RESULTS OF A PROSPECTIVE 3 YEARS FOLLOW-UP-STUDY, Thrombosis and haemostasis, 1997, pp. 872-872
EVALUATION OF HEPARIN SENSITIVITY OF APTT REAGENTS USING LYOPHILIZED HEPARIN CALIBRANTS
Authors: HAUSHOFER A HALBMAYER WM MORITZ B FISCHER M
Citation: A. Haushofer et al., EVALUATION OF HEPARIN SENSITIVITY OF APTT REAGENTS USING LYOPHILIZED HEPARIN CALIBRANTS, Thrombosis and haemostasis, 1997, pp. 1226-1226
AK-CALIBRANT, AN INR CALIBRATION SET - RESULTS FROM 3 PROFICIENCY TESTS IN EUROPE
Authors: MORITZ B LANG H HALBMAYER WM LEGENSTEIN E FISCHER M WEINSTOCK N PATSCHEKE H GEORGE J DENNIS S
Citation: B. Moritz et al., AK-CALIBRANT, AN INR CALIBRATION SET - RESULTS FROM 3 PROFICIENCY TESTS IN EUROPE, Thrombosis and haemostasis, 1997, pp. 2856-2856
COMPARISON OF A NEW AUTOMATED KINETICALLY DETERMINED FIBRINOGEN ASSAY
Authors: HALBMAYER WM FISCHER M LEGENSTEIN E KAISER E
Citation: Wm. Halbmayer et al., COMPARISON OF A NEW AUTOMATED KINETICALLY DETERMINED FIBRINOGEN ASSAY, Haemostasis, 27(1), 1997, pp. 49-50
NEUTROPENIA WITH TICLOPIDINE PLUS ASPIRIN
Authors: HAUSHOFER A HALBMAYER WM PRACHAR H
Citation: A. Haushofer et al., NEUTROPENIA WITH TICLOPIDINE PLUS ASPIRIN, Lancet, 349(9050), 1997, pp. 474-475
A HITHERTO UNKNOWN SPLICE-SITE DEFECT IN THE PROTEIN-S GENE (PROS1) -THE MUTATION RESULTS IN ALLELIC EXCLUSION AND CAUSES TYPE-I AND TYPE-III PROTEIN-S DEFICIENCY
Authors: MUSTAFA S PABINGER I VARADI K HALBMAYER WM LECHNER K SCHWARZ HP FISCHER M MANNHALTER C
Citation: S. Mustafa et al., A HITHERTO UNKNOWN SPLICE-SITE DEFECT IN THE PROTEIN-S GENE (PROS1) -THE MUTATION RESULTS IN ALLELIC EXCLUSION AND CAUSES TYPE-I AND TYPE-III PROTEIN-S DEFICIENCY, British Journal of Haematology, 99(2), 1997, pp. 298-300
MUTATIONS IN THE HUMAN FACTOR-XII GENE
Authors: SCHLOESSER M ZEERLEDER S LUTZE G HALBMAYER WM HOFFERBERT S HINNEY B KOESTERING H LAMMLE B PINDUR G THIES K KOHLER M ENGEL W
Citation: M. Schloesser et al., MUTATIONS IN THE HUMAN FACTOR-XII GENE, Blood, 90(10), 1997, pp. 3967-3977
MONITORING OF HIGH-DOSE INTRAVENOUS HEPARIN-THERAPY - A CONTRIBUTION TO THE SAFETY OF HEPARIN MONITORING
Authors: HAUSHOFER A HALBMAYER WM RADEK J FISCHER M
Citation: A. Haushofer et al., MONITORING OF HIGH-DOSE INTRAVENOUS HEPARIN-THERAPY - A CONTRIBUTION TO THE SAFETY OF HEPARIN MONITORING, Clinical and applied thrombosis/hemostasis, 2(3), 1996, pp. 177-184
A MODIFICATION OF THE CLASSIC APC-RESISTANCE-DETECTING TEST AND A NEWAMIDOLYTIC TEST FOR DETERMINATION OF APC-RESISTANCE APPLIED IN 10 PATIENTS HETEROZYGOUS FOR FACTOR-V LEIDEN MUTATION ON AND BEFORE ORAL ANTICOAGULATION THERAPY
Authors: HALBMAYER WM HAUSHOFER A ANGERER V KRUGLUGER W DOLESCHEL W HOPMEIER P FISCHER M
Citation: Wm. Halbmayer et al., A MODIFICATION OF THE CLASSIC APC-RESISTANCE-DETECTING TEST AND A NEWAMIDOLYTIC TEST FOR DETERMINATION OF APC-RESISTANCE APPLIED IN 10 PATIENTS HETEROZYGOUS FOR FACTOR-V LEIDEN MUTATION ON AND BEFORE ORAL ANTICOAGULATION THERAPY, Clinical and applied thrombosis/hemostasis, 2(2), 1996, pp. 146-148
THE DISCRIMINATION OF FACTOR-XII DEFICIENCY AND LUPUS ANTICOAGULANT
Authors: HALBMAYER WM HAUSHOFER A ANGERER V FISCHER M
Citation: Wm. Halbmayer et al., THE DISCRIMINATION OF FACTOR-XII DEFICIENCY AND LUPUS ANTICOAGULANT, Thrombosis and haemostasis, 75(4), 1996, pp. 698-699
ANTI-GM1 ANTIBODIES IN POLYNEUROPATHIES OF UNKNOWN ORIGIN
Authors: FINSTERER J MUELLBACHER W HALBMAYER WM FISCHER M MAMOLI B
Citation: J. Finsterer et al., ANTI-GM1 ANTIBODIES IN POLYNEUROPATHIES OF UNKNOWN ORIGIN, Journal of Clinical Pathology, 49(5), 1996, pp. 422-425
PLATELET SIZE, FIBRINOGEN AND LIPOPROTEIN(A) IN CORONARY HEART-DISEASE
Authors: HALBMAYER WM HAUSHOFER A RADEK J SCHON R DEUTSCH M FISCHER M
Citation: Wm. Halbmayer et al., PLATELET SIZE, FIBRINOGEN AND LIPOPROTEIN(A) IN CORONARY HEART-DISEASE, Coronary artery disease, 6(5), 1995, pp. 397-402
COMPARISON OF A NEW AUTOMATED KINETICALLY DETERMINED FIBRINOGEN ASSAYWITH THE 3 MOST USED FIBRINOGEN ASSAYS (FUNCTIONAL, DERIVED AND NEPHELOMETRIC) IN AUSTRIAN LABORATORIES IN SEVERAL CLINICAL POPULATIONS ANDHEALTHY CONTROLS
Authors: HALBMAYER WM HAUSHOFER A SCHON R RADEK J FISCHER M
Citation: Wm. Halbmayer et al., COMPARISON OF A NEW AUTOMATED KINETICALLY DETERMINED FIBRINOGEN ASSAYWITH THE 3 MOST USED FIBRINOGEN ASSAYS (FUNCTIONAL, DERIVED AND NEPHELOMETRIC) IN AUSTRIAN LABORATORIES IN SEVERAL CLINICAL POPULATIONS ANDHEALTHY CONTROLS, Haemostasis, 25(3), 1995, pp. 114-123
CHANGES OF ANTITHROMBIN-III VALUES, PROTH ROMBIN FRAGMENT-1-III COMPLEX AFTER IMPLANTATION OF CORONARY PALMAZ-SCHATZ STENTS(2 AND THROMBIN ANTITHROMBIN)
Authors: DITTEL M HAUSHOFER A SPIEL R HALBMAYER WM PRACHAR H FISCHER M MLCZOCH J
Citation: M. Dittel et al., CHANGES OF ANTITHROMBIN-III VALUES, PROTH ROMBIN FRAGMENT-1-III COMPLEX AFTER IMPLANTATION OF CORONARY PALMAZ-SCHATZ STENTS(2 AND THROMBIN ANTITHROMBIN), Zeitschrift fur Kardiologie, 84(1), 1995, pp. 22-29
EXTERNAL QUALITY ASSURANCE - AN ESSENTIAL ELEMENT OF THE QUALITY MANAGEMENT IN CLINICAL LABORATORIES
Authors: HALBMAYER WM LEGENSTEIN E KAISER E
Citation: Wm. Halbmayer et al., EXTERNAL QUALITY ASSURANCE - AN ESSENTIAL ELEMENT OF THE QUALITY MANAGEMENT IN CLINICAL LABORATORIES, Wiener Klinische Wochenschrift, 107(16), 1995, pp. 500-506
QUALITY ASSURANCE OF HIGH-DOSE IV HEPARIN TREATMENT EXEMPLIFIED BY PATIENTS IMPLANTED WITH CORONARY PALMAZ-SCHATZ STENTS
Authors: HAUSHOFER A HALBMAYER WM PRACHAR H FISCHER M
Citation: A. Haushofer et al., QUALITY ASSURANCE OF HIGH-DOSE IV HEPARIN TREATMENT EXEMPLIFIED BY PATIENTS IMPLANTED WITH CORONARY PALMAZ-SCHATZ STENTS, Angiology, 46(4), 1995, pp. 305-311
COURSE OF THROMBIN ACTIVATION MARKERS IN PATIENTS IMPLANTED WITH PALMAZ-SCHATZ STENTS - FIRST EXPERIENCES WITH A POST-INTERVENTIONAL ANTICOAGULATION REGIMEN
Authors: HAUSHOFER A HALBMAYER WM DITTEL M PRACHAR H MLCZOCH J FISCHER M
Citation: A. Haushofer et al., COURSE OF THROMBIN ACTIVATION MARKERS IN PATIENTS IMPLANTED WITH PALMAZ-SCHATZ STENTS - FIRST EXPERIENCES WITH A POST-INTERVENTIONAL ANTICOAGULATION REGIMEN, Blood coagulation & fibrinolysis, 5(5), 1994, pp. 697-706
THE PREVALENCE OF POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C (APC RESISTANCE) AMONG PATIENTS SUFFERING FROM STROKE OR VENOUS THROMBOSIS AND AMONG HEALTHY-SUBJECTS
Authors: HALBMAYER WM HAUSHOFER A SCHON R FISCHER M
Citation: Wm. Halbmayer et al., THE PREVALENCE OF POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C (APC RESISTANCE) AMONG PATIENTS SUFFERING FROM STROKE OR VENOUS THROMBOSIS AND AMONG HEALTHY-SUBJECTS, Blood coagulation & fibrinolysis, 5(1), 1994, pp. 51-57
PREVALENCE OF FACTOR-XII (HAGEMAN-FACTOR) DEFICIENCY AMONG 426 PATIENTS WITH CORONARY HEART-DISEASE AWAITING CARDIAC-SURGERY
Authors: HALBMAYER WM HAUSHOFER A RADEK J SCHON R DEUTSCH M FISCHER M
Citation: Wm. Halbmayer et al., PREVALENCE OF FACTOR-XII (HAGEMAN-FACTOR) DEFICIENCY AMONG 426 PATIENTS WITH CORONARY HEART-DISEASE AWAITING CARDIAC-SURGERY, Coronary artery disease, 5(5), 1994, pp. 451-454
HIGH-DOSE INTRAVENOUS MELPHALAN IN A PATIENT WITH MULTIPLE-MYELOMA AND OLIGURIC RENAL-FAILURE
Authors: PECHERSTORFER M ZIMMERROTH I WEIDINGER S IRSIGLER K HALBMAYER WM ULRICH W FISCHER M BAUMGARTNER G
Citation: M. Pecherstorfer et al., HIGH-DOSE INTRAVENOUS MELPHALAN IN A PATIENT WITH MULTIPLE-MYELOMA AND OLIGURIC RENAL-FAILURE, The Clinical investigator, 72(7), 1994, pp. 522-525
INFLUENCE OF LUPUS ANTICOAGULANT ON A COMMERCIALLY AVAILABLE KIT FOR APC-RESISTANCE
Authors: HALBMAYER WM HAUSHOFER A SCHON R FISCHER M
Citation: Wm. Halbmayer et al., INFLUENCE OF LUPUS ANTICOAGULANT ON A COMMERCIALLY AVAILABLE KIT FOR APC-RESISTANCE, Thrombosis and haemostasis, 72(4), 1994, pp. 645-646
THROMBOTIC RISK OF WOMEN WITH HEREDITARY ANTITHROMBIN-III-DEFICIENCY,PROTEIN C-DEFICIENCY AND PROTEIN S-DEFICIENCY TAKING ORAL-CONTRACEPTIVE MEDICATION
Authors: PABINGER I SCHNEIDER B SCHARRER I HACHWUNDERLE V LECHNER K EICHINGER S KYRLE PA VINAZZER H LAMMLE B DEMARMELSBIASIUTTI F TILSNER V MARX G SEIFRIED E GABELMANN A ASPOCK G FISCHER M HALBMAYER WM
Citation: I. Pabinger et al., THROMBOTIC RISK OF WOMEN WITH HEREDITARY ANTITHROMBIN-III-DEFICIENCY,PROTEIN C-DEFICIENCY AND PROTEIN S-DEFICIENCY TAKING ORAL-CONTRACEPTIVE MEDICATION, Thrombosis and haemostasis, 71(5), 1994, pp. 548-552
Risultati: 1-25 | 26-29